Human Papillomavirus (HPV): Diagnosis and Treatment

Animal Biotechnology: Models in Discovery and Translation

Volumn , Issue , 2013, Pages 95-120

  Bharadwaj, Mausumi ^a   Hussain, Showket ^a   Tripathi, Richa ^a   Singh, Neha ^b   Mehrotra, Ravi ^a  

^a INSTITUTE OF CYTOLOGY AND PREVENTIVE ONCOLOGY   (India)

^b PANJAB UNIVERSITY   (India)

Author keywords

Bethesda Classification; Biopsy; Cancer; Cervical Cancer; Colposcopy; DNA Cytometry; HPV; Human Papillomavirus; Pap Smear; Vaccine

Indexed keywords

EID: 84902068686     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-416002-6.00006-7     Document Type: Chapter

References (35)

1. Apgar B.S., Zoschnick L., Wright T.C. The 2001 Bethesda System terminology. American Family Physician 2003, 68:1992-1998.
2. Burd E.M. Human papillomavirus and cervical cancer. Clinical Microbiology Reviews 2003, 16:1-17.
3. Butz K., Hoppe-Seyler F. Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region. Journal of Virology 1993, 67:6476-6486.
4. Das B.C., Hussain S., Nasare V., Bharadwaj M. Prospects and prejudices of human papillomavirus vaccines in India. Vaccine 2008, 26:2669-2679.
5. Donnelly J.J., Wahren B., Liu M.A. DNA vaccines: progress and challenges. Journal Immunology 2005, 175:633-639.
6. Doorbar J., Ely S., Sterling J., McLean C., Crawford L. Specific interaction between HPV-16 E1-E4 and cytokeratins results in collapse of the epithelial cell intermediate filament network. Nature 1991, 352:824-827.
7. Dyson N., Howley P.M., Munger K., Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989, 243:934-937.
8. Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer 2010, 127:2893-2917.
9. Frazer I.H. Prevention of cervical cancer through papillomavirus vaccination. Nature Reviews. Immunology 2004, 4:46-54.
10. Gasparini R., Panatto D. Cervical cancer: from Hippocrates through Rigoni-Stern to zur Hausen. Vaccine 2009, 1(Suppl. 27):A4-5.
11. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
12. Heins H.C., Dennis E.J., Pratthomas H.R. The possible role of smegma in carcinoma of the cervix. American Journal of Obstetrics and Gynecology 1958, 76:726-733. discussion 733-725.
13. Hussain S., Bharadwaj M., Nasare V., Kumari M., Sharma S., et al. Human papillomavirus infection among young adolescents in India: impact of vaccination. Journal of Medical Virology 2012, 84:298-305.
14. Kaivosoja Helsinki Institute of Technology 2008, What is Cancer.
15. Klug A., Finch J.T. Structure of viruses of the papilloma polyoma type. I. Human wart virus. Journal of Molecular Biology 1965, 11:403-423.
16. McMurray H.R., Nguyen D., Westbrook T.F., McAnce D.J. Biology of human papillomaviruses. International Journal of Experimental Pathology 2001, 82:15-33.
17. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. The New England Journal of Medicine 2003, 348:518-527.
18. Onon T.S. History of human papillomavirus, warts and cancer: what do we know today?. Best Practice & Research. Clinical Obstetrics & Gynaecology 2011, 25:565-574.
19. Parkin D.M., Bray F. The burden of HPV-related cancers. Vaccine 2006, 3(24 Suppl):S3/11-25. Chapter 2.
20. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA: A Cancer Journal for Clinicians 2005, 55:74-108.
21. Quinn M.A., Benedet J.L., Odicino F., Maisonneuve P., Beller U., et al. Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. International Journal of Gynaecology and Obstetrics 2006, 1(Suppl. 95):S43-103.
22. Sankaranarayanan R., Bhatla N., Gravitt P.E., Basu P., Esmy P.O., et al. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal. Vaccine 2008, 12(Suppl. 26):M43-52.
23. Scotto J., Bailar J.C. Rigoni-Stern and medical statistics. A nineteenth-century approach to cancer research. Journal of the History of Medicine and Allied Sciences 1969, 24:65-75.
24. Sellers W.R., Kaelin W.G. Role of the retinoblastoma protein in the pathogenesis of human cancer. Japanese Journal of Clinical Oncology 1997, 15:3301-3312.
25. Syverton J.T., Berry G.P. The cultivation of the virus of St. Louis encephalitis. Science 1935, 82:596-597.
26. Thierry F. Transcriptional regulation of the papillomavirus oncogenes by cellular and viral transcription factors in cervical carcinoma. Virology 2009, 384:375-379.
27. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. The Journal of Pathology 1999, 189:12-19.
28. zur Hausen H. Human genital cancer: synergism between two virus infections or synergism between a virus infection and initiating events?. Lancet 1982, 2:1370-1372.
29. zur Hausen H. Viruses in human cancers. Science 1991, 254:1167-1173.
30. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nature Reviews. Cancer 2002, 2:342-350.
31. Gynecological Cytopathology CERVIX with clinical aspects, (2007) (2nd ed.). Suresh Bhambhani, Mehta publishers.
32. The Health Professionals HPV Handbook (HPV and cervical cancer). Walter Prendiville, Philip Davies, Taylor and Francis.
33. Albuquerque N.M. Cervical cancer in New Mexico. A handbook for health care providers 1997.
34. Cancer, What's It Doing in My Life? A Personal Journal of the First Two Years of Chemotherapy in the Career of a Cancer Patient (1997) (2nd ed.). Mary Alice Geier Paperback, (128 Pages) Published by Hope Pub House.
35. Cancer and Its Management. Robert Souhami, Jeffrey Tobias (2005) (5th ed.). Paperback, (533 pages) Published by Blackwell Science Inc.